Profile
Stephen Lahue Cartt is currently a Director at Neurelis, Inc. He was previously a Director at Lineage Cell Therapeutics, Inc., a Senior Director-Strategic Marketing at Elan Pharmaceuticals, LLC, a Director at Asterias Biotherapeutics, Inc., a Director at TXP Pharma AG (Switzerland), a Principal at ALZA Corp., the Chief Operating Officer at Questcor Pharmaceuticals, Inc., and the COO-Autoimmune & Rare Diseases Business Unit at Mallinckrodt Plc.
He holds an MBA from Santa Clara University and an undergraduate degree from the University of California, Davis.
Steve Cartt active positions
| Companies | Position | Start |
|---|---|---|
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Director/Board Member | 01/01/2020 |
Former positions of Steve Cartt
| Companies | Position | End |
|---|---|---|
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Director/Board Member | 01/01/2023 |
| ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 25/06/2017 |
| LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 28/02/2016 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 01/10/2014 |
| QUESTCOR PHARMACEUTICALS INC | Chief Operating Officer | 01/08/2014 |
Training of Steve Cartt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Keenova Therapeutics Plc
Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Health Technology |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Steve Cartt
















